ImmunoGen signs licensing agreement with Bayer HealthCare for TAP technology - MarketLine Financial Deals

ImmunoGen signs licensing agreement with Bayer HealthCare for TAP technology

ImmunoGen signs licensing agreement with Bayer HealthCare for TAP technology - MarketLine Financial Deals
ImmunoGen signs licensing agreement with Bayer HealthCare for TAP technology
Published Oct 21, 2008
2 pages — Published Oct 21, 2008
Price US$ 45.00  |  Buy this Report Now

About This Report

  
Abstract:

ImmunoGen, Inc., a US-based biotechnology company that develops targeted anticancer products, has entered into an exclusive worldwide license agreement with Bayer HealthCare AG, a Germany-based company engaged in the discovery and manufacture of healthcare and medical products, to use ImmunoGen's Tumor-activated prodrug (TAP) technology to develop anticancer compounds to an undisclosed target found on solid tumors.

  
Source:
Document ID
MA00286_081023
Country
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "ImmunoGen signs licensing agreement with Bayer HealthCare for TAP technology" Oct 21, 2008. Alacra Store. Dec 03, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/ImmunoGen-signs-licensing-agreement-with-Bayer-HealthCare-for-TAP-technology-2052-226>
  
APA:
MarketLine Financial Deals. (2008). ImmunoGen signs licensing agreement with Bayer HealthCare for TAP technology Oct 21, 2008. New York, NY: Alacra Store. Retrieved Dec 03, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/ImmunoGen-signs-licensing-agreement-with-Bayer-HealthCare-for-TAP-technology-2052-226>
  
US$ 45.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.